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Binding and Degradation of Platelet
Thrombospondin by Cultured Fibroblasts
Thrombospondin is a component of platelet alpha granules
and is released upon activation ofplatelets with thrombin (1).
Platelet thrombospondin is a 450,000-mol-wt protein com-
posed of three 160,000-mol-wt disulfide-bonded subunits (2,
3). After release from the alpha granules, thrombospondin
becomes bound to the platelet membrane where it may me-
diate interactions with other platelets (4) or the endothelial
substratum (5). Thrombospondin has recently been shown to
be synthesized by cultured endothelial cells (6-8), smooth
muscle cells(9), and fibroblasts (9, 10). In culture, thrombos-
pondin is found in culture medium and the extracellular
matrix (9, 10). Cell-synthesized thrombospondin is structur-
ally and immunologically similar to thrombospondin purified
from platelets (6, 8). Cultured fibroblasts synthesize and se-
crete several other molecules that become incorporated into
the extracellular matrix, including fibronectin (11, 12), colla-
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ABSTRACT
￿
Thrombospondin was purified from human platelets and labeled with '251, and its
metabolism was quantified in cell cultures of human embryonic lung fibroblasts. 125 1-Throm-
bospondin bound to the cell layer. The binding reached an apparent steady state within 45
min. Trichloroacetic acid-soluble radioactivity was detected in the medium after 30 min of
incubation; the rate of degradation of 125 1-thrombospondin was linear for several hours
thereafter. Degradation of 1251-thrombospondin was saturable . The apparent Km and Vm,X for
degradation at 37°C were 6 x 10-'M and 1 .4 x 105 molecules per cell per minute, respectively.
Degradation was inhibited by chloroquine or by lowering the temperature to 4°C. Experiments
in which cultures were incubated with thrombospondin for 45 min and then incubated in
medium containing no thrombospondin revealed two fractions of bound thrombospondin .
One fraction was localized by indirect immunofluorescence to punctate structures; these
structures were lost coincident with the rapid degradation of 50-80% of bound 125 1-throm-
bospondin. The second fraction was localized to a trypsin-sensitive, fibrillar, extracellular
matrix. 125 1-Thrombospondin in the matrix was slowly degraded over a period of hours. Binding
of 1251-thrombospondin to the extracellular matrix was not saturable and indeed was enhanced
at thrombospondin concentrations >3 x 10-8 M. The ability of 1251-thrombospondin to bind
to extracellular matrix was diminished tenfold by limited proteolytic cleavage with trypsin .
Degradation of trypsinized 1251-thrombospondin was also diminished, although to a lesser
extent than matrix binding. Heparin inhibited both degradation and matrix binding. These
results suggest that thrombospondin may play a transitory role in matrix formation and/or
organization and that specific receptors on the cell surface are responsible for the selective
removal of thrombospondin from the extracellular fluid and matrix.
gen (11, 13), and proteoglycans (13). Thrombospondin binds
to heparin (2) and has been shown recently to interact with
fibronectin (5, 14) and collagen (5).
In the present study, we quantified the metabolism of 125j_
labeled platelet thrombospondin by fibroblast cell layers.
Thrombospondin bound in two fractions that were distin-
guished by their relative rates of turnover. One fraction of
thrombospondin was degraded within minutes by a saturable,
endocytic process. The remainder was localized to the extra-
cellular matrix and was degraded more slowly over several
hours.
MATERIALS AND METHODS
Materials:
￿
Ham's nutrient medium (F-12) and Hanks' balanced salt
solution were obtained from Grand Island Biological Co. (Grand Island, NY).
Fetal calfserum was from Sterile Systems (Logan, UT). Bio-Gel P-300, heparin-
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0The Rockefeller University Press - 0021-9525/84/01/0022/07 $1 .00agarose and electrophoresis materials were from Bio-Rad Laboratories (Rich-
mond, CA) . Na"1 was from New England Nuclear(Boston, MA). Fluorescein-
conjugated rabbit anti-mouse IgG was from Cappel Laboratories (Cochranville,
PA). N-Ethylmaleimide was from Pierce ChemicalCo. (Rockford, IL). Materials
for autoradiography were from Kodak (Rochester, NY). Heparin and other
biochemicals were from Sigma Chemical Co. (St . Louis, MO) . Human plasma
fibronectin was purified from a by-product of Factor VIII production (15).
Type 1 collagen from fetal bovine skin (16) and fibrinogen (17) and a2-
macroglobulin (18) from human plasma were purified according to published
procedures.
Cell Culture:
￿
Human embryonic lung fibroblast cells were derived
from a locally established strain (Dr. Catherine Reznikoff, University ofWis-
consin). Cells were grown in F-12 nutrient medium containing 10% fetal calf
serum, 100 U/ml penicillin, 50 ug/ml streptomycin and 2 ug/mI fungezone.
Cellswere customarily split 1:10 every 7 d, and experiments were done on cells
between passages 4 and 15 . All experiments were done using confluent cell
layers in 60-mm tissue culture plates. At confluence, cultures contained -5 x
105 cells, as determined after trypsinization by enumeration in a hemocytom-
eter.
Preparation of Isolated Matrices : Isolated cell matrices were
prepared from confluent embryonic lung fibroblast cultures by extraction with
1 % deoxycholate in 20 mM Tris-HCI buffer (pH 8.3) containing 2 mM
phenylmethylsulfonylfluoride, 2 mM ethylene diamine tetraacetic acid, 2mM
methyl maleimide, and 2mM iodoacetic acid. Extractions werecarried out for
10 min at room temperature. Matrices were rinsed three times with Hanks'
balanced salt solution before use.
Purification and Iodination of Thrombospondin : Throm-
bospondin was purified from thrombin-activated human platelets by gel filtra-
tion chromatography on Bio-Gel P-300 and affinity chromatography on hepa-
rin-agarose as described previously (8) . Thrombospondin concentration was
calculated on the basis of a published extinction coefficient (3). Purified
thrombospondin, -200 wg,wasiodinatedwith 1 mCi Na"5 I bythechloramine-
T method (19). The iodinated protein was repurified on heparin agarose and
eluted with 0.55M sodium chloride in 10mM Tris-HCI, pH 7 .4 . The specific
activity ofthe labeled molecule was generally0.5 mCi/mg protein . 'nI-Throm-
bospondin was mixed with phenylmethylsulfonylfluoride-treated bovineserum
albumin, l mg/ml, dialyzed against 10 mM Tris-HCI containing 150 mM
sodium chloride, and frozen at -70°C until use. The integrity of the labeled
molecule was assessed by PAGE in SDS with and without reduction (Fig. 1) .
Reduced thrombospondin (Fig . 1, lane c) migrated primarily as a 160,000-mol-
wt dalton polypeptide . There were minor bands of 145,000, 103,000, and
80,000 mol wt which were seen in reduced but not unreduced thrombospondin
(in Fig. 1, compare lane c to lane a) .
Monoclonal Antibody to Thrombospondin : Preparation of
mouse monoclonal antibody to human platelet thrombospondin has been
described previously (10) . The IgG fraction from the mouse ascites fluid was
purified by chromatography on DEAE-cellulose. The antibody was used in
immunofluorescence experiments (see below) and to quantify human and
bovine thrombospondin by enzyme-linked immunoabsorbent assay (10).
Binding and Degradation of Thrombospondin by Cell Lay-
ers :
￿
Confluent cell layers were incubated with ' 25I-thrombospondin in F-12
containing 0.1% albumin (binding medium) . To quantify binding and degra-
dation, we usually mixed the iodinated protein with unlabeledthrombospondin
as described in the figure or table legends . Proteolytic degradation of throm-
bospondin by the cultures was monitored by the appearance of radioactivity in
the medium which was soluble in 10% trichloroacetic acid . To determine the
amount of thrombospondin bound in the cell layer, we removed medium
containing "I-thrombospondin, and the cell layer was rinsed three times in
Hanks' buffered salt solution, and then scraped into 1 M sodium hydroxide.
Radioactivity was determined in a gamma counter . To estimate background
binding and degradation, we preincubated blank culture dishes with complete
medium (F-12 ; 10% fetal calf serum) for one h at 37°C, rinsed, and subjected
to the same procedures described above .
Immunofluorescence : For indirect immunofluorescent staining,
cells were grown on glass coverslips until confluent. Cultures were then incu-
bated with purified thrombospondin (1 or 20 yg/ml) in binding medium for
45 min at 37°C . At 45 min, the thrombospondin-containing medium was
removed, the cell layers were rinsed, and one set of cultures was fixed and
stained . A duplicate set was "chased" in binding medium containing no
thrombospondin for 3 h before fixation and staining. Fixation was done for 10
min at room temperature with 1 % paraformaldehyde in 0 .1 M sodium phos-
phate, pH 7.4. Coverslips were cleared with acetone for 10 min at -20°C.
Coverslips were stained with a purified IgG fraction (100 tag/ml in Hanks'
buffered salt solution) of mouse monoclonal antibody to thrombospondin.
Staining was carried out for 1 h at room temperature. Coverslips were washed
for 30 min with three changes of Hanks' balanced salt solution and stained
FIGURE 1
￿
Autoradiography of intact (lane a and c) and trypsinized
(lanes b and d) ' 251-thrombospondin . '251-Thrombospondin was
trypsinized for 10 min at 37°C with 2 Irg/ml trypsin . The reaction
was stopped with a 10-fold (wt/wt) excess of soybean trypsin
inhibitor . Each well contained 100,000 cpm of radioactivity, and
lanes c and d were reduced with 2-mercaptoethanol before elec-
trophoresis on an 8% polyacrylamide gel .
with fluoroscein-conjugated rabbit anti-mouse IgG diluted 1 :100 in Hanks'
buffered salt solution . Coverslips were put onto glass slides in Tris-buffered
saline, pH 7 .4, containing 1 mg/ml phenylenediamine . Photography was per-
formed with a Leitz microscope equipped with epifluorescence and phase
contrast.
Gel Electrophoresis :
￿
SDS PAGE was performed on slabs of 8%
separating and 3.3% stacking gels using a discontinuous buffer system (20) .
Marker proteins (see reference 8) were visualized by staining with Coomassie
Brilliant Blue. For visualizing ' 251-thrombospondin, slabs were dried and au-
toradiographed with XAR-2 film.
RESULTS
Time Course of Binding and Turnover of
Thrombospondin by Fibroblast Cell Cultures
Confluent cell layers ofhuman embryonic lung fibroblasts
were incubated with " -s1-thrombospondin for 4 h, and binding
and degradation of thrombospondin by the cell layers were
quantified (Fig. 2) . Thrombospondin became rapidly associ-
ated with the cell layer, and maximum binding was achieved
within 45 min . Degradation of thrombospondin by the cell
layers was first detected at 30 min and proceeded at a linear
rate between 45 and 150 min . The amount of thrombospon-
din degraded after 4 h represented 12% of the added radio-
activity . The remaining 88% was precipitable in trichloro-
acetic acid and migrated as intact thrombospondin in poly-
acrylamide gels (data not shown) . When 1251-thrombospondin
was allowedto bind to cell layers for 45 min and then "chased"
(Fig. 2, arrow), the bound fraction had two fates . After 3 h of
"chase," 60% of the material bound at 45 min had been
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FIGURE 2 Time course of binding and degradation of thrombo-
spondin by confluent human embryonic lung fibroblasts . Cultures
were incubated with 3 ml of binding medium containing 1 Ag/ml
thrombospondin (300,000 cpm/ml) for the designated times . Cell
layers were either incubated continuously with ' 251-thrombospon-
din (9, N) or incubated with '251-thrombospondin for 45 min and
then "chased" (arrow) with fresh binding medium containing no
thrombospondin (p, p). Degradation was monitored by the ap-
pearance of trichloroacetic acid-soluble radioactivity (A, EI) in the
medium . Cell layers were solubilized in sodium hydroxide to de-
termine bound thrombospondin (0, p) .
200
degraded . The rate of degradation decreased during the
"chase" period, and the remaining 121I-thrombospondin re-
mained bound in the cell layer. Bound 121-thrombospondin
was judged to be intact thrombospondin when analyzed by
SDS PAGE (data not shown) . Intermediate degradation prod-
ucts of thrombospondin were never detected, either in the
medium or in the cell layer, indicating that thrombospondin
was rapidly degraded into small fragments .
lmmunofluorescent Localization of
To investigate further the two fractions of cell-associated
thrombospondin, we incubated cell layers with purified plate-
let thrombospondin, and thrombospondin was then localized
by indirect immunofluorescence using a mouse monoclonal
antibody prepared against platelet thrombospondin . The
monoclonal antibody recognizes human thrombospondin
synthesized by cultured cells and the bovine thrombospondin
present in fetal calf serum (10) . Therefore, cell layers were
incubated with two concentrations ofpurified human platelet
thrombospondin, either 1 or 20 kg/ml . The increased fluores-
cent staining seen in cultures labeled with 20 wg/ml throm-
bospondin was assumed to represent the exogenous throm-
bospondin added during the experiment. Cultures were in-
cubated with thrombospondin for 45 min . At 45 min, one set
of cultures was processed for immunofluorescence, and the
other set was "chased" for 3 h. Cultures incubated for 45 min
showed both a punctate and a fibrillar type fluorescencewhen
fixed with paraformaldehyde and acetone (Fig. 3, a and c) .
This pattern was similar to that detected when cell layers
grown in fetal calf serum are analyzed by immunofluores-
cence with antithrombospondin (9, 10) . Punctate fluorescence
was much less prominent in cells fixed only with paraform-
aldehyde (data not shown), suggesting that some of the punc-
tate structures wore intracellular . "Chased" cell layers ex-
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hibited fibrillar fluorescence patterns (Fig . 3, b and d) . The
fibrillar fluorescence patterns were similar in cell layers fixed
only in paraformaldehyde, indicating that these fibrils were
extracellular (data not shown). These data in combination
with Fig . 2 suggest that the punctate fluorescence represents
thrombospondin . in endocytic vesicles destined for degrada-
tion in lysosomes . These structures were not present after a
3-h "chase" and therefore do not represent synthetic pools .
Rather, the diffuse perinuclear staining pointed out by arrows
in Fig. 3, c and d probably represents recently synthesized
thrombospondin in the rough endoplasmic reticulum and
Golgi complex .
Effect of Concentration on Degradation and
Matrix Binding of Thrombospondin
Cell layers were incubated with increasing concentrations
of 'ZSI-thrombospondin, and both the rate ofthrombospondin
degradation and the amount of thrombospondin bound in
the matrix were determined (Fig . 4a) . The rate of thrombo-
spondin degradation approached saturation at concentrations
>20 gg/ml. Thrombospondin binding in the extracellular
matrix, however, did not saturate over the concentration
range studied . Instead, the proportion of thrombospondin
bound into the matrix increased with increasing thrombo-
spondin concentrations, suggesting that deposition of throm-
FIGURE 3
￿
Localization of thrombospondin in cell layers by indirect
immunofluorescence . Confluent cell layers of lung fibroblasts were
incubated with either 20 ug/ml (a and b) or 1 Ag/ml (c and d) of
purified platelet thrombospondin for 45 min at 37°C . After 45 min,
one set of cultures (a and c) were fixed and stained for thrombo-
spondin . A second set of cultures (b and d) were "chased" for 3 h
in binding medium containing no thrombospondin before fixation
and staining . e is a phase contrast of c . x 200.c
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FIGURE 4
￿
Effect of concentration on binding and degradation of
thrombospondin by fibroblast cell layers. Confluentcell layers were
incubated with 2 ml of binding medium containing increasing
concentrations of a mixture of 1211-thrombospondin and unlabeled
thrombospondin. The specific activity of this mixture was 4 UCi/
mg. Degradation rates of "'I-thrombospondin (0-0) were deter-
mined between 45 and 180 min of incubation . For determination
of bound thrombospondin (O-O), cultures were incubated with
1211-thrombospondin for 45 min, "chased" for 3 h in unlabeled
medium, and solubilized in 1 M sodium hydroxide. Binding
(O- -O) and degradation (0- -*) on blank plates were also moni-
tored. The turnover data were replotted by the Lineweaver-Burke
method forcalculation of kinetic constants (b).
bospondin into the extracellular matrix is enhanced by higher
thrombospondin concentration. Background binding and
turnover of thrombospondin on blank tissue culture plates
were also determined over a range of thrombospondin con-
centrations (Fig. 4a). There was no detectable degradation of
thrombospondin, and only a small amount ofbinding (<10%
ofthe amount bound in the cell layer) was observed.
The turnover data in Fig. 4a were replotted on a double
reciprocal plot for determination of kinetic constants (Fig.
46). The data were fitted to a straight line by linear regression
with a correlation coefficient (r) = 0.998. The apparent Mi-
chaelis-Menten constant (Km ) and maximum rate ofturnover
(Vmaz) in four experiments were 29 ± 17 ug/ml and 55 ± 25
ng/min (x ± SD), respectively. Thus, Km for degradation was
^-6 x 10-1 M, and Vmaz was approximately 1 .4 x 105 mole-
cules degraded per cell per minute.
Inhibition of Degradation and Matrix Binding of
Thrombospondin
Inasmuch as various amines have been shown to block
receptor-mediated protein degradation, probably by raising
the pH ofendocytic vesicles (21) or lysosomes (22), the effects
of such amines on thrombospondin metabolism were tested.
Chloroquine at > 1 x 10-° M completely blocked thrombo-
spondin degradation (Fig. 5). In similar experiments, both
methylamine and ammonium chloride were also effective
inhibitors of thrombospondin turnover at concentrations of
1 x 10-z M (data not shown).
Degradation of 1251-thrombospondin was inhibited by low
temperature, i.e., there was no detectable increase in trichlo-
roacetic acid-soluble radioactivity in the medium of cultures
incubated at 4°C even after4 h ofincubation (data not shown).
The ability of fragments oftrypsinized thrombospondin to
be bound and degraded by fibroblasts was also tested (Table
I). Mild trypsinization of "'I-thrombospondin resulted in two
labeled fragments, one having a nonreduced molecular weight
of -300,000 and a second of <30,000 which moved at the
dye front (Fig. 1). The large fragment was composed of
disulfide-bonded subunits with individual sizesof 90,000 mol
wt. This fragment has been designated the tryptic-resistant
core of thrombospondin (2, 3, 23). The <30,000-mol-wt
FIGURE 5
￿
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thrombospondin (40,000
cpm/ml)for 180 min in the
presence of increasing
concentrations of chloro-
quine. Degradation rates
were calculated between
45 and 180 min of incuba-
tion.
TABLE I
Binding andDegradation of Trypsinized Thrombospondin
% Total trichloroacetic acid
precipitable cpm added
Degraded Bound
After
180
135-45
￿
At 45
￿
min
min min chase
1251-Thrombospondin (400,000 cpm) wastreated with trypsin (2 ug/ml in Tris-
buffered saline), inactive or "mock" trypsin (2 ug/mlTrypsin, 20rag/ml soybean
trypsin inhibitor), or Tris-buffered saline alonefor 10 min at 37°C. Soybean
trypsin inhibitor, 20 ug/ml, was then added to trypsin-treated and control
incubations. 1251-Thrombospondin in bindingmedium (100,000 cpm/ml) was
incubated with cell layers. Degradation was measured between 45 and 135
min of incubation as appearance of trichloroaceticacid-soluble radioactivity
in the medium. Fordetermination of binding, cell layers were labeled for 45
min and then scraped directly into 1 M sodium hydroxide or incubated for
180 min in binding medium containing no thrombospondin before solubili-
zation in sodium hydroxide. Determinations represent the average from
duplicate plates which did not differ by >3%.
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Control "'I-thrombospondin 5.7 5.1 1.7
"Mock-trypsinized" 1211-thrombo- 6.1 5.5 1.5
spondin
Trypsinized "'I-thrombospondin 4.0 2.1 0.17labeled fragment had a size of 22,000-mol-wt when analyzed
on a more concentrated gel (data not shown). The 30,000-
mol-wt heparin-binding fragment described by Lawler and
Slayter (23) labeled very poorly with 1251 and was barely
visualized by autoradiography. Trypsinized thrombospondin
was bound in the cell layer at -30% of control levels. This
amount represented thrombospondin present in the matrix
and in the endocytic pool. Binding to the extracellular matrix
was most affected by trypsinization; trypsinized thrombo-
spondin bound at <10% of control levels. Degradation of
trypsinized thrombospondin over the 90-min time course was
reduced by 33% .
Thrombospondin has been reported to interact with colla-
gen (5), fibrinogen (14), fibronectin (5, 14), and heparin (2,
23). These molecules, as well as a2-macroglobulin, a glycopro-
tein with a size and pl similar to those of fibrinogen and
fibronectin, were tested for possible effects on degradation
and matrix incorporation of thrombospondin. Like throm-
bospondin, a2-macroglobulin has been shown to be specifi-
cally bound and degraded by cultured fibroblasts (24-26).
The results in Table II indicate that collagen, fibronectin,
fibrinogen, and a2-macroglobulin had little effect on throm-
bospondin binding or turnover, whereas heparin was a potent
inhibitor of both processes.
Thrombospondin Metabolism in Cell Matrices
To determine whether thrombospondin couldbind directly
to the extracellular matrix, we prepared isolated matrices by
extraction of confluent cell layers with 1 % deoxycholate.
Indirect immunofluorescence of the deoxycholate insoluble
matrix indicated that these matrices contained fibronectin,
collagen, and thrombospondin (data not shown). Similarly
prepared matrices (12, 13, 27) have also been shown to
contain proteoglycans, hyaluronic acid, and some actin. Iso-
lated matrices and confluent cell cultures were incubated with
TABLE II
Effect of Various Macromolecules on Thrombospondin
Metabolism
Cell layers were incubated with 12'1-thrombospondin (1 gg/ml; 250,000 cpm/
ml) in binding medium containingthe above macromolecules at the indicated
concentrations. Degradation was measured as trichloracetic acid-soluble
radioactivityappearing in the medium between 45 and 180 min of incubation.
Matrix incorporation was measured as the amount of radioactivity remaining
in the cell layer after labeling cultures for 45 min and "chasing" for 3 h in
binding medium contz.ining no thrombospondin. The data are expressed as
percent of control levels, and determinations represent averages of duplicates
that varied by <5%.
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"'I-thrombospondin for up to 4 h. "'I-Thrombospondin was
degraded in intact cultures (Fig. 6a) but not by isolated
matrices (Fig. 6 b). Initial binding to be the matrix proceeded
at a slower rate than to intact cultures, and binding was linear
over 4 h. Matrices that were "chased" after 45 min (Fig. 6b,
arrow) lost little thrombospondin over the subsequent 3 h.
That exogenous thrombospondin was bound to the matrix in
deoxycholate-extracted cell layers was demonstrated by indi-
rect immunofluorescent localization of thrombospondin to
matrix fibrils (data not shown).
Thrombospondin turnover in the matrices of intact cell
layers and cell-free matrices was also compared over a longer
timespan (Fig. 7). In intact cell layers, 75% of bound IZSI-
thrombospondin was lost in a biphasic manner from the cell
layer over a period of 44 h. Loss of "'I-thrombospondin from
the cell layers was accompanied by a corresponding increase
in trichloroacetic acid-soluble radioactivity in the culture
medium. In contrast, only 20% of bound thrombospondin
was lost from the isolated matrices after 44 h. None of the
radioactivity in culture medium of isolated matrices became
soluble in trichloroacetic acid, suggesting that the small pro-
portion of intact thrombospondin that was lost from the
matrices was lost by diffusion rather than by degradation.
Degradation of matrix-bound thrombospondin in intact cell
layers was inhibited by chloroquine, even in the presence of
medium conditioned by cells not treated with chloroquine
(data not shown). This finding suggests that the turnover of
matrix-bound thrombospondin occurs intracellularlyand not
by the action of a secreted protease.
' 2'I-Thrombospondin bound to the matrix of intact cell
layers was treated with trypsin and various extractants (Table
III). Of the agents tested, trypsin (88% release) and 3 M
guanidine hydrochloride (64% release) were the most effec-
tive. Although heparin blocked thrombospondin incorpora-
tion into the matrix (Table II), heparin, 100 /ig/ml, extracted
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FIGURE 6 Thrombospondin binding and degradation by isolated
cell matrices. "'I-Thrombospondin (5 wg/ml, 400,000 cpm/ml) was
incubated with intact (a) and 1% deoxycholate-extracted (b) fibro-
blast cell layers. Cultures were either incubated continuously with
1251-thrombospondin (0-0, /-/) or incubated with 1251-throm-
bospondin for 45 min and then "chased" (arrow) for 3 h with fresh
binding medium containing no thrombospondin (O- -O, O- -I]).
Degradation was monitored by the appearance of trichloroacetic
acid-soluble radioactivity (I/, 0) in the medium. Cell layers were
solubilized in 1 M sodium hydroxide to determine bound throm-
bospondin (0,O). Background binding (30-120 ng)anddegradation
(1-20 ng) on blank plates have been subtracted from each time
point.
Macromolecule Degradation
(% of control)
Matrix Incorpo-
ration
Collagen
25 tug/ml 92 118
Fibronectin
25 jug/ml 95 112
125jug/ml 85 106
Fibrinogen
25 Ilg/ml 100 108
125Ag/ml 92 96
a2-Macroglobulin
25 Ilg/m1 94 102
125jug/ml 94 104
Heparin
5jug/ml 27 12
25 tug/ml 30 100
DISCUSSION
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FIGURE 7
￿
Persistence of thrombospondin in the extracellular ma-
trix. "'I-Thrombospondin (5.5 ug/ml, 400,000 cpm/ml) was incu-
bated with intact cell layers (0, 0) and deoxycholate-extracted
matrices (p, p) for 45 min in binding medium and then "chased"
for 3 h in binding medium containing no thrombospondin. At this
time (0 time in the graph), there were 177 ng of thrombospondin
bound in the intact cell layer and 354 ng bound in the isolated
matrix. Less than 25 ng of thrombospondin bound to serum-coated
plates handled in a similar manner. Plates were incubated further
in F-12 containing 10% fetal calf serum and monitored for degra-
dation (I, p) and binding(*, p) as described in the legend to Fig.
6.
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TABLE III
Extraction of Matrix Bound Thrombospondin
Enzyme or extractant
￿
% Extracted
"'I-Thrombospondin (5 pg/ml; 170,000 cpm/ml) was incubated with cell
layers for 45 min in binding medium. Labeled medium was removed, and
cell layers were "chased" in binding medium for 3 h. Cell layers, containing
168 ng of thrombospondin, were scraped into 1 ml of Hanks' buffered salt
solution, transferred to centrifuge tubes, and treated with extractants for 10
min at room temperature. Trypsinization was stopped with a 10-fold (wt/wt)
excess of soybean trypsin inhibitor. Insoluble material was removed by
centrifugation, and radioactivity in the supernatant was determined. Deter-
minations represent average of duplicates that varied <5%.
little thrombospondin from the matrix when compared to
Hanks' buffered salt solution alone. Sodium chloride, 1 M,
and 1 % deoxycholate were moderately effective extractants.
The present experiments were modeled after our recent in-
vestigations of fibronectin (28). Like thrombospondin, fibro-
nectin is synthesized by cells in culture and incorporated into
the extracellular matrix (9, 10). In addition, plasma fibronec-
tin in serum-containing growth medium becomes incorpo-
rated into the extracellular matrix of the cultured cells (28,
29). Plasma fibronectin also becomes localized in connective
tissues in vivo (30). As described in the introduction, throm-
bospondin synthesized by cultured cells and platelet throm-
bospondin are very similar ifnot identical. Thrombospondin
is present in plasma in only trace amounts (31, 32), and
concentrations of exogenous thrombospondin in vivo are
probably significant only in localized woundareas where there
is degranulation ofplatelets. Fetal calf serum contains 30-40
Ag/ml thrombospondin as assayed by our enzyme-linked
immunoabsorbent assay (10; unpublished results). Therefore,
the usual conditions of cell culture mimic a wound area in
the sense that exogenous thrombospondin is present in serum-
containing growth medium.
Using 1211-thrombospondin purified from human platelets,
we demonstrated that exogenous thrombospondin does bind
to cell layers of cultured human embryonic lung fibroblasts.
A portion of the bound thrombospondin was degraded to a
form that is soluble in trichloroacetic acid. The remainder
formed a more stable association with the cell layer. This
stable fraction of thrombospondin could be localized to the
extracellular matrix (Fig. 3) where it was present in fibrillar
structures reminiscent of fibrils knownto contain fibronectin,
collagen, and proteoglycans (13). We also prepared throm-
bospondin in the presence of calcium to maintain calcium-
sensitive structures within the molecule (33). Thrombospon-
din prepared in this manner was bound and degraded by
cultured fibroblasts with kinetics similar to those shown in
Fig. 2.
Immunofluorescent localization of thrombospondin in
punctate structures after 45 min and the subsequent disap-
pearance of thrombospondin in these structures after a 3-h
"chase" (Fig. 3) coincident with the rapid appearance of
trichloroacetic acid-soluble radioactivity in the medium (Fig.
2) suggest that the punctate fluorescence seen in cells stained
with antithrombospondin (9, 10) represents thrombospondin
in coated pits, endocytic vesicles, and lysosomes. Degradation
of thrombospondin was a saturable process (Fig. 4a) that
couldbe inhibited by weak bases (Fig. 5) and low temperature
(4°C). Rapid turnover of thrombospondin, therefore, is very
similar to the specific and saturable receptor-mediated endo-
cytosis and degradation ofa2-macroglobulin (24-26) and low
density lipoprotein (34). The fact that trypsinized fragments
of thrombospondin were degraded less rapidly than intact
thrombospondin (Table I) also indicates that turnover occurs
by specific endocytosis rather than a more generalized process,
i.e., fluid phase pinocytosis (35). Degradation of thrombo-
spondin (Table II) and low densitylipoprotein (36) is inhibited
by heparin. Both proteins bind to heparin (23, 37). In the case
of low density lipoprotein, heparin may compete with the cell
surface receptor for ligand binding (36). The same may be
true for thrombospondin.
Binding ofthrombospondin to the extracellular matrix was
not saturable. Indeed, increasing concentrations of thrombo-
spondin resulted in higher proportions of thrombospondin
remaining in the matrix (Fig. 4a). Thus, interactions among
molecules at higher concentrations may alterthe way in which
thrombospondin associates with the matrix, and exogenous
thrombospondin concentration may regulate the content of
matrix-bound thrombospondin. Thrombospondin bound di-
rectly to isolated cell matrices prepared by deoxycholate ex-
traction (Fig. 6b). Plasma fibronectin, in contrast, does not
bind directly to the extracellular matrix, but to a cellular
receptor that apparently mediates its assembly into the matrix
(28).
Full release of thrombospondin from the matrix required
proteolysis or strong denaturation (Table III), suggesting that
thrombospondin is tightly bound to the matrix. Similar ex-
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Trypsin, 100 Ag/ml 88
Trypsin, 10 frg/ml 88
Guanidine, 3 M 64
Deoxycholate, 1 % 34
Sodium chloride, 1 M 34
Heparin, 100,ug/ml 23
Urea, 3 M 22
Triton, 1% 20
Hanks' buffered salt solution 15traction methods must be employed to remove "5I-plasma
fibronectin from the matrix (28; and unpublished observa-
tions). Matrix-bound thrombospondin was slowly degraded
and, after24 h, 60% ofit was in a trichloroacetic acid-soluble
form (Fig. 7). In contrast, there is no degradation of matrix-
bound 125I-fibronectin over the same time period (28).
Thrombospondin has been reported to interact with fibro-
nectin and collagen when one of the molecules is adsorbed
onto plastic (5, 14). However, collagen and fibronectin did
not have significant effects on thrombospondin binding or
degradation by fibroblast cell layers. The inhibition of throm-
bospondin binding to matrix by heparin suggests a possible
role for heparan sulfate proteoglycans in the metabolism of
thrombospondin by these cell cultures. Heparan sulfate pro-
teoglycans are present in the extracellular matrix (13) and
may be integral components of the plasma membrane (38,
39). Heparin and a concentration of sodium chloride consid-
erably higher than that required to disrupt heparin-thrombo-
spondin binding (3), however, were only slightly effective in
releasing thrombospondin from the matrix. Thus, further
studies are needed to sort out the interactions responsible for
initial and long-term binding of thrombospondin to the ma-
trix.
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